-36%

Cartalax Peptide

Original price was: $69.99.Current price is: $44.99.

Cartalax, also known as AED or AC-4, is a synthetic tripeptide composed of the amino acids alanine, glutamic acid, and aspartic acid. It has been studied for its role in regulating cartilage and bone metabolism by interacting with cellular pathways involved in the function of chondrocytes and thyroid C cells, making it an important peptide in musculoskeletal research.

Category: Product ID: 5985

Description

Cartalax is a synthetic tripeptide made up of the amino acids alanine, glutamic acid, and aspartic acid. It has been studied for its ability to interact with cellular processes involved in cartilage and bone health, particularly within chondrocytes and thyroid C cells. Research suggests that Cartalax may support joint integrity by encouraging collagen production, an essential protein that provides strength and structure to connective tissues, while helping protect cartilage cells from apoptosis, or programmed cell death. In addition, the peptide has demonstrated anti-inflammatory properties by reducing the activity of matrix metalloproteinases (MMPs), enzymes responsible for breaking down cartilage, and by limiting the production of inflammatory signaling molecules. Studies also indicate that Cartalax may play a role in calcium regulation through its interaction with thyroid C cells, potentially supporting healthy bone metabolism and bone density.

Core Benefits of Cartalax Peptide

When we talk about cartalax peptide benefits, what we’re really looking at are practical outcomes that aim to improve joint health: smoother movement, less joint discomfort, better recovery from joint stress, and greater long-term joint resilience. Here’s how things break down in plain English. If you want a deeper breakdown of mechanisms, see what Cartalax peptide is and how it works.

1. Cartilage regeneration and connective-tissue support

Cartalax may help the body’s natural repair systems work more efficiently — particularly in connective tissues. It seems to stimulate cell proliferation in certain cell types (which means more cells working to rebuild tissue) and may reduce programmed cell death in those tissues.

For cartilage, which naturally has limited regenerative capacity, this is especially relevant.

2. Joint comfort, reduced inflammation and better mobility

Beyond simply rebuilding tissue, cartalax appears to help reduce inflammation and promote joint comfort. When joints are less inflamed, you feel less stiffness and pain — this in turn supports enhanced mobility and overall joint function.

One source describes cartalax peptide as “designed to support joint health, promote cartilage resilience, and improve mobility.”

3. Enhanced joint function and long-term joint health

By supporting cartilage health and connective tissue integrity, cartalax may contribute to long-term joint health. That means better joint function today and maintaining joint health for future wear and tear.

Because the joint tissues rely on healthy extracellular matrix and well-functioning cartilage cells, anything that helps those underlying systems may improve long term joint health and joint resilience.

4. Recovery from joint injuries or strain

If you’ve experienced joint injuries or physical activity that stresses your joints, which can be common in an active lifestyle, (think knees, hips, shoulders), cartalax might support the recovery process. By boosting connective tissue repair, reducing inflammation, and supporting cartilage cells, it can be an option for those who want to bounce back quicker with less long-term joint degeneration. For targeted recovery protocols, explore Cartalax Peptide For Joint Recovery: Guide To Cartilage Repair, Arthritis & Injury Support. For research guidance on timing and structure, review Cartalax peptide dosage recommendations.

5. Cartilage and Joint Health Support

Let’s dig into how cartalax may support cartilage health and joint health more specifically — in everyday terms.

cartalax Peptide Dosage

The Cartalax Peptide (Ala-Glu-Asp-Leu) is a tetrapeptide bioregulator developed by Khavinson for cartilage and bone tissue.

  • Concentration: 2 mg/mL (20 mg vial + 10 mL bac water, in portions).
  • At 2 mg/mL200 µg = 10 units daily for 10 days.
  • Cartalax targets chondrocyte/osteoblast gene expression normalization.
  • Combine with BPC-157 for synergistic joint repair — different mechanisms, complementary targets.
  • One 20 mg vial: 100 doses at 200 µg/day — 10 complete 10-day courses possible.

Cartalax Peptide Specifications

Property Value
Peptide Sequence Ala-Glu-Asp
Molecular Formula C12H19N3O8
Molecular Weight 333.29 g/mol
PubChem CID 87815447
Synonyms Ala-Glu-Asp, alanyl-glutamyl-aspartic acid, T-31 peptide, H-Ala-Glu-Asp-OH

 

Cart0
Cart0